Clinical Trial Imaging Market Grow by USD 2,219.8 Mn by 2032 | Growth Driven by Growing Demand For Computed Tomography
September 11, 2023 05:48 ET
|
Market.Us
New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Global Clinical Trial Imaging Market size is likely to top a valuation of US$ 2,219.8 Million by 2032 from USD 1,067.3...
R&D Innovations and Radiology Advancements Drive Global Imaging CRO Market Growth through 2023-2027
September 04, 2023 10:22 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Services...
R&D Innovations and Radiology Advancements Drive Global Imaging CRO Market Growth through 2023-2027
September 04, 2023 10:20 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Services...
R&D Innovations and Radiology Advancements Drive Global Imaging CRO Market Growth through 2023-2027
September 04, 2023 10:17 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Services...
R&D Innovations and Radiology Advancements Drive Global Imaging CRO Market Growth through 2023-2027
September 04, 2023 10:14 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Services...
XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer
August 30, 2023 09:00 ET
|
XBiotech Inc.
AUSTIN, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. announced today completion of enrollment of the Phase II portion of its 1-BETTER study—a Phase I/II randomized, double-blind,...
XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial
August 08, 2023 11:47 ET
|
XBiotech Inc.
AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to...
Virtual Clinical Trials Global Market Report 2023: Industry Key Players ICON, plc, PRA Health Sciences, IQVIA, Covance, and Parexel International at the Forefront of Market Growth
August 08, 2023 06:18 ET
|
Research and Markets
Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The virtual clinical trials market...
Technology-enabled Drug Discovery Research Report 2023: AI Integration into Drug Discovery Remains on an Upward Trajectory, Increasing Almost 40% as of 2022
August 08, 2023 04:43 ET
|
Research and Markets
Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Growth Indicators for Technology-enabled Drug Discovery" report has been added to ResearchAndMarkets.com's offering. Innovative Business Models...
Global Clinical Trial Packaging Market Insights 2023-2030: Novel Drugs Approval Sparks Surge in Clinical Trials, Boosting Packaging Demand
August 04, 2023 06:58 ET
|
Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Packaging Market Outlook 2023-2030" report has been added to ResearchAndMarkets.com's offering. The Global Clinical Trial...